NIOSH Releases Guidance on General Safe Practices for Working with Engineered Nanomaterials in Research Laboratories
Updated: 2012-05-30 22:59:15
Nano and Other Emerging Chemical Technologies Law Blog : Lawyer Attorney Bergeson Campbell Law Firm Nanotech and Chemical Legal Developments Published By Bergeson Campbell , . P.C Regulatory legal developments involving nanotechnologies nanomaterials About Contact Services Archives Home Occupational Health and Safety Issues NIOSH Releases Guidance on General Safe Practices for Working with Engineered Nanomaterials in Research Laboratories NIOSH Releases Guidance on General Safe Practices for Working with Engineered Nanomaterials in Research Laboratories Posted on May 30, 2012 by Lynn L . Bergeson Email This Print Comments Trackbacks Share Link The National Institute for Occupational Safety and Health NIOSH has posted a document entitled General Safe Practices for Working with Engineered

There’s a now a video of a talk that I gave at Lloyd’s of London, a unique, global insurance institution founded in 1688.
The Financial Services and Nanotechnology Knowledge Transfer Networks (in collaboration with the Lighthill Risk Network) hosted the talk, and I directed my remarks primarily to insurance underwriters and risk professionals. It’s a bit [...]
Zyvex Technologies and ENVE Composites have demonstrated the superiority of a proprietary nanostructured composite in downhill cycling.
Darpa has launched a "Living Foundries" program to bring an engineering perspective to synthetic biology to greatly accelerate progress through standardization and modularization.
Nancy K Mize, PhD, Scientist, Innovator, and CEO of GENOGEN Inc., will continue Foresight's local Bay Area community events with a lecture "GENOGEN: Regenerating Skin for Life". GENOGEN is developing products that activate resident skin stem cells to stimulate local areas of regeneration of skin naturally – the way children heal.
Templates made from polymer nanofibers enable the formation of long-lived silicon nanostructures that store ten times as much charge as do graphite battery terminals.
Nanoparticles targeted to cancer cells by antibodies cannot achieve enough specificity to kill drug-resistant cancer cells while sparing normal cells, but can achieve enough specificity to produce nanobubbles only in cancer cells, so the drug only enters cancer cells.
Doping carbon nanotubes with boron while they are being formed produces a novel molecular architecture formed by boron induced kinks and linkages. These nanosponges can be used repeatedly to absorb and retrieve or burn spilled oil.